Next, the study looked at people who started ART between 2015 and 2019 and subsequently survived for at least a year, when their follow-up data began to be collected. The 2015 cut-off was chosen as this was when treatment guidelines changed to recommend treatment for all people diagnosed with HIV, no matter what their CD4 count was.